Patent details

EP2478362 Title: USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP2478362
PCT Application Number:
PCT/US/2010/049545
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP108179995
PCT Publication Number:
WO/2011/035274
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF THE SPARC MICROENVIRONMENT SIGNATURE IN THE TREATMENT OF CANCER
French Title of Invention:
UTILISATION D'UNE SIGNATURE DE MICROENVIRONNEMENT SPARC DANS LE TRAITEMENT DU CANCER
German Title of Invention:
VERWENDUNG DER SPARC-MIKROUMGEBUNGS-SIGNATUR BEI DER KREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
20/09/2010
Grant date:
11/05/2016
EP Publication Date:
11/05/2016
PCT Publication Date:
24/03/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/07/2012
EP B1 Publication Date:
11/05/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
20/09/2016
Expiration date:
20/09/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/09/2010
 
 

Name:
Abraxis BioScience LLC
Address:
11755 Wilshire Boulevard, Los Angeles, CA 90025, United States (US)

Inventor

1

Name:
TRIEU Vuong
Address:
United States (US)

2

Name:
DESAI Neil
Address:
United States (US)

Priority

Priority Number:
276969 P
Priority Date:
18/09/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/53;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages